3i Deutschland
3i Investments plc
5H Ltd
ABN AMRO Capital
ACE BioSciences
AdAstra Erste Beteiligungs GmbH
ADIRA
Ahrens & Behrent, Financial Dynamics GmbH
Alantos Pharma
Alta Partners
AMT B.V.
Androclus Therapeutics
APALEXO Biotechnologie GmbH
Apax Partners
Apovia AG
Arakis Ltd.
Aravis Venture Associates
ARPIDA Ltd.
Artemis Pharmaceuticals
Artesian Therapeutics, Inc.
AstraZeneca
Atlas Venture
atugen AG
Aurum Ventures
Aventis
Aventis Pharma Deutschland GmbH
Aventis Pharmaceutical
Avidex Limited
Avlar Bioventures Ltd. Avontec GmbH
Axaron Bioscience AG
Axxima Pharmaceuticals AG
Bank Julius Baer
BankInvest Bio Venture
Bank Vontobel AG
BankInvest
Bavarian Ministry for Economic Affairs, Transport and Technology
Bayerische Landesbank
Bayern Kapital GmbH
Baytech Venture Capital
BEITEN BURKHARDT GOERDELER
Binder Stüber & Partner GmbH
Biobank Technology Ventures LLC
BioConnect AG
BioExec Ventures LLC
Biofrontera Pharmaceuticals Holding AG
Bio-Light, Life Science Investments
Bio-M AG
BioMedInvest
biomedpark M.e.d.i.e.n GmbH
BioMedTec Franken e.V.
BioNetWorks GmbH
BioPortfolio
Bioseeker Group
Biotechnology Competence Network
BioWorld International
Bloomberg
Bloomberg News
Boehringer Ingelheim GmbH
Boerse Online
Borean Pharma A/S
Börsenmedien AG
Bosch Graf von Stosch Jehle Patentanwälte
Bridgehead Pharmalicensing Group Ltd
Brilleon Capital AG
Cambrex Corporation
Cambridge Consultants Ltd
Cap Gemini Ernst & Young
Capsulution NanoScience AG
CCR Chevrillon Philippe
Chiral Quest, Inc.
CIMAB S.A
Citigroup
Clariden Bank
Collins Stewart
CombinatoRx, Inc. Combinature Biopharm AG
Crawford Capital
CREABILIS therapeutics srl Credit Suisse Private Banking
Critical I Limited
Curidium Ltd
Cyclacel
Cytochroma Inc.
Danske Private Equity A/S
Definiens AG
Deutsche Bank AG
Deutsche Börse AG
Deutsche Industrievereinigung Biotechnologie (DIB)
DeveloGen
Dunhaw Capital Limited
DVC Deutsche Venture Capital
DyoDelta Biosciences Ltd

Earlybird GmbH & Co. KG
EIF European Investment Fond
Eli Lilly and Company
EMEA
Ernst & Young AG
ESBATech AG
Euromedica
EUROPROTEOME AG
Extorel Private Equity Advisers GmbH
Favrille, Inc.
First Ventury Equity GmbH
FIT Biotech Plc
FOCUS CDD GmbH
Focus Money
Freshfields Bruckhaus Deringer
FRIZ Biochem GmbH
Future Capital AG
G2M Cancer Drug AG
Gamida-Cell Ltd
Garching Innovation GmbH
General Research GmbH
Genzyme GmbH
German Business Concepts Gilde Biotechnology & Nutrition Fund
GlaxoSmithKline
Global Life Science Ventures AG
Global Life Science Ventures GmbH
Global Life Science Ventures Ltd
GNI
GoingPublic Media AG
Goldfish Holdings
Goldman Sachs International
Halsin Partners Ltd.
HBM Partners AG
HCC De Facto GmbH
HealthCap
Hugin IR Services Deutschland GmbH
HypoVereinsbank AG
IBM (UK) Ltd
IKB Private Equity GmbH
Imperial College Innovations
Index Ventures
Industrifonden (Swedish Industrial Development Fund)
Infineon Technologies AG
Infineon Ventures GmbH
Ingenium Pharmaceuticals
InnoMed Ventures
INSEAD
IntegraGen SA
Intercell AG
IQ Corporation BV
IsoTis OrthoBiologies
Israel Seed Partners
Jeffries International
Johnson & Johnson Development Corporation
Katan Associates
Kayenburg AG
Kirchhoff Consult AG
KIRCHHOFF Equity Consult GmbH
KPMG
KPMG Beiten Burkhardt
L. Hepner and Associates LTD
Landesbank Baden-Württemberg
Laverda Limited
LCF Rothschild Group
Lehman Brothers
Library House
LifePoint Inc.
Linklaters
Logical Venturs
London Stock Exchange
Lorantis Ltd
LSP
Lynkeus BioTech GmbH
MacroPore Biosurgery, Inc.
Madrona Partners, Inc.
MC Services
Medabiotech S.A
Medical Strategy GmbH.
MediGene AG
MedVenture Partners GmbH
Merck Finck & Co
Merlin Biosciences
Merrill Lynch International
Micromet AG
Morgan Lewis & Bockius LLP
Morphochem AG
MPM Capital
Mulligan BioCapital AG
Munich Biotech AG
MWG-Biotech AG
NanoCyte Inc.
Nature Publishing Group
Nature Reviews Drug Discovery
NeoMed Management
new commercial room
Newron Pharmaceuticals S.p.A.
Nextech Venture AG / BioVision AG

NIB Capital Private Equity N.V.
Nomura International
Noonan Russo
Northbank Communications Ltd
Novartis Pharma
Novo A/S
Nuevolution A/S
Opexa Pharmaceuticals, Inc.
OptimalOffice
Oxagen
Paul Capital Partners
Perlegen Sciences, Inc.
Perseus-Soros Biotechnology Fund, LP
Pharmaprojects
Pharming Group N.V.
PIERIS Proteolab AG
Polaris Venture Partners
PolyTechnos
PricewaterhouseCoopers Corporate Finance
Privateq Advisors AG
Proskelia S.A.S
Psimei Pharmaceuticals plc
PwC
r.toder.consulting
Rejuvenon Corp.
Response
Reuters
Sal. Oppenheim jr. & Cie. KGaA
Salmedix, Inc
Schoenenberger + Partners SA
SCHWARZ FINANCIAL COMMUNICATION
Scottish Equity Partners
Scottish Widows Investment Partnership
Seed GmbH
Seed Management Associates
Siemens
SIGA Technologies, Inc.
SiREEN AG
Sitka Limited
SJ Berwin Knopf Tulloch Steininger
Sloning Biotechnology GmbH Steininger
Solving International
Sofinnova Partners
S-Refit AG
SÜD VENTURE CAPITAL GmbH
Sueddeutsche Zeitung
Suterscience
Switch Biotech AG
SWX Swiss Exchange
Sympore GmbH
Syngenta International AG
Techno Venture Management
TeGenero AG
The BioScience Ventures Group
The Entrepreneurial Group e.V.
The Genetics Company
The Trout Group
Transgene
Trigen Ltd
TTP Ventures
U3 Pharma
UBS Investment Bank
University of Cambridge
University of Tübingen Clinic
Venture Valuation VV AG
Vernalis
VI Partners AG
Warburg Pincus GmbH
Warburg Pincus International LLC
WestLB Panmure
WGZ-Bank
Wilex AG
Windhover Information Inc - In
Value Relations IR Services GmbH
Vecta Ltd.
VentureCapital Magazin
Venture Valuation AG
Viscardi AG
Vivo Start Up
WEGAsupport GmbH
Wellington Partners Venture Capital GmbH
Womble Carlyle Sandridge & Rice PLLC
Xantos Biomedicine AG
Xerion Pharmaceuticals AG
Zero Stage Capital